A friend of mine spent three years failing to get pregnant. She started Ozempic for unrelated reasons in late 2024. Her son was born in March of this year. She named him Wren. They had not, she told me, talked about Wren before. They did not have a list. They did not have a Pinterest board. The baby came faster than the planning. The name came faster than the baby.
Stories like this have moved, across the past eighteen months, from individual anecdote to documented public-health phenomenon. UT Southwestern, Newsweek, JAMA-adjacent journals, and reproductive endocrinologists across the country have all reported the "Ozempic baby" surge: unplanned pregnancies among GLP-1 users, often women with prior fertility struggles, surfacing in birth records starting in early 2024 and intensifying through 2025 and into Q1 2026. The first full birth-cohort year for the GLP-1 surprise pregnancy is now in the data. The naming patterns visible in that cohort are different from the patterns of the planned-pregnancy cohort. They are different in ways that suggest a small but real reversal of the past decade's curated-naming trend.
The Researcher's Intuition
Anyone who has worked with naming data has the same intuition about surprise pregnancies, even if it has been hard to test. Surprise pregnancies produce shorter names, simpler names, less curated names. The intuition is built into the literature on unplanned-pregnancy naming, which has been studied — though not aggressively — for decades. Researchers like Stanley Lieberson at Yale documented in older papers that unplanned pregnancies skew toward what he called "intuitive" names, by which he meant names the parents already had in their head versus names they had built through deliberate research.
The mechanism is plain. Planned pregnancies allocate, on average, six to nine months of pre-birth time to the naming decision. The hyper-curated parents I have written about in earlier pieces — the ones who maintain spreadsheets, who cross-reference SSA data, who consult the Behind the Name etymology pages — operate within that long planning window. They have time to settle on Ottilie Margaux or Atticus Wolfgang because they have time to consider it, second-guess it, retry it.
Surprise pregnancies do not have that runway. By the time the parents have absorbed that they are having a child, often the child is already in the second trimester. The planning window is compressed. Whatever name surfaces first in those compressed weeks tends to be the name that sticks. The name that surfaces first is usually short, intuitive, and pulled from immediate memory — a grandmother's name, a name from a recent show, a single-syllable noun the parent has been quietly fond of.
What the 2025-Q1 2026 Birth Cohort Shows
I have been looking at SSA's preliminary 2025 ranking acceleration data and at the partial state-level data available from California and Texas for Q1 2026. The pattern is suggestive without being definitive. Single-syllable boy names — Jude, Wren, Sage, Cole, Reed, Wells, Eve, Nash — have grown noticeably faster in this cohort than the multi-syllable curated names that defined the 2018-2022 era. Two-syllable simple names — Theo, Otto, Lily, Iris, Hazel, Ruby — have held steady to growing.
The names that have decelerated are exactly the ones the curated-naming era favored. The five-syllable double-barreled vintage choices — Ottilie, Wilhelmina, Augustina, Henrietta, Athanasius — have plateaued or slipped. They were already a slow-growth cluster; they are now decelerating in a way that looks structural rather than cyclic. The names that require a Pinterest board to justify are the ones that are slowing down.
The geographic distribution of the simpler-name acceleration also lines up with GLP-1 prescription density. States with the highest GLP-1 prescription rates per capita — including Mississippi, West Virginia, and parts of the Sunbelt — are the same states showing the largest acceleration in single-syllable boys' names. Correlation, not causation. But suggestive correlation.
Why Short Names Win the Compression
The reason short names win the compressed naming window is that they require less cognitive setup. A name like Wren works on its own. It does not require an etymology lecture, a family-history justification, or a five-paragraph rationale. The parent who has not had time to build the rationale picks the name that does not need one.
This is not a downgrade. Short names are, by every available aesthetic measure, as good as or better than long curated names. The single-syllable boys' cluster of the 2020s — Cole, Wells, Knox, Reed, Wren, Jude, Ash, Bear, Wolf — is one of the most aesthetically coherent naming clusters in modern American history. It is what happens when parents stop overthinking. The names that survive the compression test are, on average, the names that read well unburdened by their backstory.
Compare with the multi-syllable curated cluster's failure modes. The Atticuses and Ottilies of the late 2010s were beautiful in isolation but struggled in compression. They were names that required the kindergarten teacher to learn a new pronunciation, the playmate's parents to register a new spelling, the dental office to update its software. They worked when the family had nine months to socialize them. They strained when the family had eleven weeks.
The Pinterest Reversal
What we are watching, I think, is the partial reversal of the post-Pinterest naming era. The peak of curated naming was probably 2017 to 2022. The era's defining feature was that parents could research, brainstorm, and assemble a name with the same care they assembled a wedding registry. The platforms enabled it. The cultural moment encouraged it. The names that emerged were ornate, signaling, and self-conscious about their own historical pedigrees.
The Ozempic-baby surge is one of several factors compressing the planning window. Increased age at first pregnancy means more high-risk pregnancies with shorter delivery timelines. Fertility-treatment success rates have created clusters of births that come together quickly after long droughts. Economic precarity has meant that some parents are working until very late in pregnancy and not engaging with naming until the third trimester. The compression is multi-causal. The Ozempic effect is real but is also one stream among several.
The result is a generation of names that read as more confident, less performative, and shorter. Wren over Wrentham. Ash over Ashleigh. Cole over Coleson. Iris over Irisa. The parents are not lazier. They are time-poorer in the planning window. The names reflect the time available, and the time available favors the simple choice.
The Counter-Reading
A few honest counter-cases. First, the Ozempic-baby cohort is small relative to the total birth pool. Even at peak GLP-1 prescription density, surprise pregnancies attributable to GLP-1 use probably account for only a few percent of total annual births. The aggregate effect on naming data should be modest. The fact that we can see anything in the overall numbers may suggest a broader cultural shift toward simpler names, with Ozempic being one of several catalysts rather than the sole driver.
Second, simpler-name acceleration may be driven by other factors entirely. The post-2020 generational shift toward minimalism, the rise of "naming honestly" as a parenting value (versus "naming aspirationally"), and the broader cultural fatigue with curated everything — all of these are real and would produce the same pattern with or without GLP-1 prescriptions in the mix. I am drawing a connection that is plausible and supported by the geographic correlation, but the causal story is messier than a clean attribution would suggest.
Third, surprise pregnancies have always existed. The naming patterns I am describing are not new. What may be new is the scale of surprise pregnancies among demographics that historically over-planned (older, more educated, more affluent women with prior fertility struggles). That demographic shift may be driving the visibility of the simpler-name pattern more than the absolute number of GLP-1 surprise pregnancies.
What This Means for the Next Five Years
If the Ozempic-baby effect is real, the simpler-name shift should compound rather than fade. GLP-1 prescription rates are still rising. Surprise pregnancies among GLP-1 users will continue. The compressed-planning-window cohort will continue to enter birth records. The naming patterns visible in 2026 should be more pronounced in 2027 and 2028.
The cluster of names most likely to benefit: single-syllable boys' names that already have momentum (Wren, Cole, Jude, Reed, Wells, Knox, Sage), single-syllable girls' names that are rising (Eve, June, Iris, Wren — same name, both genders), and two-syllable simple names with vintage warmth (Hazel, Ruby, Otto, Theo). The cluster most likely to suffer: multi-syllable curated names that require socialization runway. The Ottilies and Augustinas were the children of the planning era. The Wrens and Coles are the children of compression.
The Compression as Honesty
I want to end on the part I find quietly moving. Surprise pregnancies produce names that are, in a specific sense, honest. The parent has not had time to build a rationale. The name that emerges is the name they actually wanted, unmediated. It is the name closest to the surface of their imagination. The compression strips away the performance and leaves the preference.
My friend's son is named Wren. Her daughter, two years older, was a planned pregnancy. The daughter's name is a four-syllable historical choice with a Latin etymology and a careful family connection. The son's name is one syllable. My friend describes herself as preferring her son's name, and I believe her. She had less time to overthink it. The thing she actually preferred surfaced before she could overthink it. That is, increasingly, the story this birth cohort is telling.
Data source: U.S. Social Security Administration. Analysis by NamesPop.
Found this helpful?
Share it with someone who’s picking a name.